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Intrauterine insemination (IUI) is a widely used and cost-effective therapy for the
treatment of infertility. There have been many reports on the factors to affect
successful IUI treatment. Women’s age, the length and cause of infertility, sperm
quality such as motile sperm count, ovarian stimulation, number of mature folli-
cles, estradiol (E2) concentration on the day of hCG administration, and the type
of used catheter can influence the results of IUI.
1-8
Intrauterine manipulation or instrumental application to the cervix during
embryo transfer (ET) of in vitro fertilization (IVF) cycles is known to induce
uterine contractility,
9-11 which may reduce pregnancy rate.
12 On the other hand, the
uterine contractions at IUI may not affect clinical pregnancy rate since uterine
contraction after insemination subsides before fertilization. However, to date, there
are no studies available on the effects of tenaculum application to the cervix during
IUI cycles. Therefore, we aimed to investigate whether the use of tenaculum
affects the clinical outcomes of IUI and to evaluate the pregnancy outcomes
according to the use of tenaculum during IUI.
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Purpose: The association between tenaculum application to the cervix just before
embryo transfer and lower pregnancy rate has been reported. However, studies on
the use of tenaculum in intrauterine insemination (IUI) cycles are not available. This
study attempted to investigate whether the use of tenaculum affects the clinical
outcomes of IUI. Materials and Methods: Two hundred and thirty three CC/hMG/
IUI cycles of one hundred and forty three couples were recruited at Seoul National
University Hospital from October 2006 to December 2008. Mock insemination and
IUI with or without tenaculum application to the cervix were also performed, and
clinical pregnancy rate was compared. Results: The incidence of difficult mock
insemination at the beginning of cycle was higher in the tenaculum use group (p <
0.001). No significant statistical difference in the clinical pregnancy rate was observ-
ed between the groups with or without tenaculum application (12.1% vs. 18.5%; p=
0.175), which was not influenced by the difficulty of mock insemination. Conclusion:
The use of tenaculum during IUI may not affect the pregnancy outcome. Our results
need to be confirmed by a prospective study in a larger population.  
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Subjects
Before the collection of retrospective data, we hypothesized
that the application of tenaculum during IUI would affect
the clinical pregnancy rates by 10%, and calculated the
sample size with 0.05 of alpha error and 0.80 of power.
According to the calculation, at least the data of 164 sub-
jects were needed. During the period of 26 months from
October 2006 to December 2008, husband’s semen arti-
ficial insemination was used in 143 subfertile couples with
unexplained infertility during 233 treatment cycles. This
study was approved by the institutional review board.
Measurement of hormones
Blood samples for serum hormone assays (FSH, LH, estra-
diol-17β) were collected on the third day of natural or induc-
ed menstrual cycle. These hormones were measured by
immunoassay kits (Biosource
TM, Invitrogen, Carlsbad, Cali-
fornia, USA). Intra- and inter-assay coefficients of variation
were 1.1-2.0% and 2.4-4.4% for FSH, 1.4-3.9% and 3.4-
8.0% for LH, 4.9-5.9% and 6.1-6.2% for E2, respectively.
Mock insemination and ovarian stimulation
Mock insemination was performed at the beginning of
cycle. Difficulty was assessed as easy, moderate or difficult.
Clomiphene citrate (CC) (Clomiphene
®, Young Poong
Phamaceutical Company, Seoul, Korea) + hMG (IVF-M
®,
LG Life Sciences, Seoul, Korea) were used for stimulation.
Vaginal ultrasound examination to evaluate the number
and size of follicles and endometrial maturation was
repeated everyday or every other day. One hundred milli-
grams of CC were administered on the third day of mens-
trual cycle and administered for 5 days. Treatment with 75
to 150 IU of gonadotropins, depending on the patient’s
previous or anticipated responses, was added from the last
day of CC. The treatment was then individualized and
adjusted according to the response. When at least one
follicle reached 18 mm in diameter or 2 or more follicles
reached 17 mm in diameter, 250 µg of recombinant hCG
(Ovidrel
®, Serono, Geneva, Switzerland) was given. IUI
was then performed 36-40 hours later.
Calculation of expected number of ovulating follicles 
and E2
Since not all follicles larger than 14 mm do ovulate and
ovulation rates are dependent on the follicles size at the
time of hCG administration, we calculated the expected
number of ovulating follicles and E2 by using diameters of
stimulated follicles observed on the day of hCG adminis-
tration. The expected number of ovulating follicles and E2
were calculated by using diameters of stimulated follicles
observed on the day of hCG administration as follows:
Expected number of ovulating follicles was calculated as
0.005×(total follicle number of 6-14 mm in diameter) +
0.37×(total follicle number of 15-16 mm in diameter) +
0.73×(total follicle number of 17-18 mm in diameter) +
0.81×(total follicle number of 19-20 mm in diameter) +
0.96×(total follicle number of > 20 mm in diameter).
Expected E2 (pg/mL) was calculated as 291 + 180×(total
follicle number of ≥ 17 mm in diameter) + 64×(total
follicle number of 15-16 mm in diameter) + 18.7×(total
follicle number of 6-14 mm in diameter).
13
Sperm preparation and insemination
One and half hours before insemination and after 48-72
hours of abstinence, semen was collected at the laboratory.
After motility determination, the spermatozoa were wash-
ed free from seminal liquid and prepared for insemination.
We recorded post-wash total motile sperm count. Wallace
catheter was used for the insemination process. The end of
the catheter was placed in the center of the uterine cavity,
and the sperm preparation (0.3 mL) was injected slowly.
Tenaculum was used when insemination was difficult.
Statistical analysis 
Clinical pregnancies were defined as those with a fetal heart
beat on ultrasound. Outcome variables were compared be-
tween the tenaculum use and non-use groups. Data were
analyzed with SPSS 12.0 for Windows (SPSS Inc., Chicago,
IL, USA). Pearson’s χ 2 test or Fisher’s exact test was used to
compare proportions and Student’s t-test to compare means.
A pvalue of < 0.05 was considered statistically significant.
Age of subjects, age of husbands, duration of infertility,
body mass index, basal hormone levels and sperm para-
meters were comparable between the tenaculum use and
non-use groups (Table 1). There was no cancelled cycle.
Dose of CC and gonadotropins used, number of follicles >
14 mm, diameter of leading follicle(s), expected numbers
of ovulating follicles and E2, and endometrial thickness
were not different between the two groups. The incidence of
‘moderate’ or ‘difficult’ at mock insemination was higher in
the tenaculum use group (p < 0.001). The clinical pregnancy
rate did not differ significantly between the two groups
(12.1% vs. 18.5%; p = 0.175) (Table 2). The significance of
the results did not differ even after correction of the pre-
vious IUI cycles using Mantel-Haenszel Chi-square test.
When ‘easy’ and ‘moderate or difficult’ subgroups were
compared, the clinical pregnancy rate was not different
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between the tenaculum use and non-use groups (Table 3).
There are very few studies that investigated whether the
use of tenaculum during IUI affects the pregnancy outcome.
In IVF cycles, this issue has long been addressed by many
studies. Instrumental application to the cervix immediately
before ET can cause uterine contractions,
9-11 which may
affect the pregnancy outcomes.
12,14 
Our present data showed that clinical pregnancy rate per
cycle was 14.6%, which is comparable to a recent large
scale study from ESHRE registration data which involved
DISCUSSION
Table 3.Pregnancy Outcome According to Difficulty of Mock Insemination
Mock insemination Tenaculum application Pregnancy rate pvalue*
Easy Tenaculum (+) 12.3% (13/106) NS
Tenaculum (-) 19.5% (17/87)
Moderate & difficult Tenaculum (+) 11.4% (4/35) NS
Tenaculum (-) 0% (0/5)
NS, not significant.
*Fisher’s exact test. 
Table 1.Patient Characteristics and Sperm Parameters
Tenaculum (+) Tenaculum (-) pvalue
No. of cycles 141 92 NS
Patient age (yrs) 32.6 ± 3.6 32.8 ± 4.1 NS
Husband age (yrs) 35.1 ± 3.7 35.5 ± 4.1 NS
Duration of infertility (months) 37.5 ± 23.2 40.7 ± 32.7 NS
Body mass index (kg/m
2) 21.1 ± 2.9 21.3 ± 2.9 NS
No. of attempts 1.6 ± 1.0 1.9 ± 1.2 NS
Basal LH (mIU/mL) 4.2 ± 2.1 4.3 ± 1.9 NS
Basal FSH (mIU/mL) 4.9 ± 2.5 5.5 ± 3.2 NS
Basal E2 (pg/mL) 36.8 ± 19.9 41.3 ± 27.9 NS
Sperm number (×10
6/mL) 219.8 ± 55.3 221.6 ± 53.2 NS
Progressive motility (%) 79.3 ± 23.7 77.8 ± 26.8 NS
Total motile sperm count (×10
6/mL) 53.7 ± 21.6 53.4 ± 22.8 NS
LH, luteinizing hormone; FSH, follicle stimulating hormone; NS, not significant.
Data are presented as mean ±SD. 
Table 2. Ovulation Induction Parameters and Cycle Outcome of Intrauterine Insemination
Tenaculum (+) Tenaculum (-) pvalue
Gonadotropin dose used (amp) 6.9 ± 6.9 7.1 ± 10.1 NS
Number of follicles > 14 mm
Rt. 1.3 ± 0.9 1.3 ± 0.9 NS
Lt. 1.0 ± 0.9 0.9 ± 0.9 NS
Diameter of leading follicle (mm) 19.3 ± 1.5 19.1 ± 1.6 NS
Expected No. of ovulation 1.3 ± 0.6 1.3 ± 0.6 NS
Expected E2 (pg/mL) 625.9 ± 130.6 607.5 ± 130.9 NS
Endometrial thickness (mm) 9.2 ± 2.3 8.7 ± 2.0 NS
Difficulty at mock insemination < 0.001
Easy 106 87
Moderate 12 3
Difficult 23 2
Clinical pregnancy rate (%) 12.1% (17/141) 18.5% (17/92) NS
NS, not significant.
Data are presented as mean ±SD. 1 amp = 75 IU. 120,613 insemination cycles and revealed that the pre-
gnancy rate per cycle was 12.6% for women receiving IUI.
15
The present study showed no statistical difference in clini-
cal pregnancy rates between tenaculum use and non-use
groups (12.1% vs. 18.5%). For two by two cross-analysis,
we compared between ‘easy’ and ‘moderatate or difficult’
mock insemination groups, and no difference was observ-
ed between the two groups [15.5% (30/193) vs. 10.0%
(4/40), p = 0.263 by Fisher’s exact test]. All subgroup data
were also comparable to the pregnancy rates in other re-
ports.
15 There was no pregnancy in tenaculum non-use group
with moderate or difficult mock insemination (Table 3),
which might have resulted from the small number of cycles.
Although the incidence of difficult mock insemination at
the beginning of cycle was higher in the tenaculum use
group (Table 2), we observed a discrepancy between the
ease of mock insemination and the use of tenaculum at
IUI. Tenaculum was used in many cases even with easy
mock insemination and vice versa. Tenaculum application
after easy mock insemination may result from the change
of uterine axis caused by the enlarged ovaries, although
this can not explain all the causes of discrepancy. In
contrast, tenaculum was not used at IUI in just a few cycles
with moderate or difficult mock insemination. 
It is hard to conclude on the role of mock insemination
from our data. As mentioned above, many cycles showed
discrepancies between the ease of mock insemination and
the use of tenaculum at IUI (Table 2). Because of a limita-
tion of retrospective study, our present data should be con-
firmed by a prospective study on the efficacy of mock inse-
mination as primary endpoint. 
Another limitation of our present study is that we did not
assess the uterine contractility by any measure, therefore,
the cause of possibly altered results due to tenaculum appli-
cation cannot be evaluated. We can discuss only with
caution that the easiness at the time of mock insemination
may not affect the pregnancy outcome, considering the fact
that there was similar pregnancy rate between ‘easy’ and
‘moderate or difficult’ mock insemination groups (12.3%
vs. 11.4%) in the cycles with tenaculum application.
In conclusion, we investigated whether the use of tena-
culum affects the clinical outcomes of IUI, and concluded
that the use of tenaculum during IUI may not affect the
pregnancy outcome. However, our results need to be con-
firmed by a prospective study in a larger population.
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